China’s clinical-stage biotech company, Duality Biotherapeutics, has filed for an initial public offering (IPO) on the Hong Kong Stock Exchange. The company, specializing in antibody-drug conjugates (ADCs), aims to raise […]

Adicon, a Chinese diagnostic laboratory company, has announced its plan to raise approximately $52.29 million through a global offering in its upcoming Hong Kong listing. As part of its upcoming […]